Clinically-indicated replacement versus routine replacement of peripheral venous catheters

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 4, 2013, Pages

  Webster, Joan ^a,b,c   Osborne, Sonya ^d   Rickard, Claire M ^a,b   New, Karen ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CATHETER INFECTION; CATHETER OCCLUSION; FOLLOW UP; HUMAN; MORTALITY; OPEN STUDY; PAIN; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; THROMBOPHLEBITIS; CATHETERIZATION; DEVICE REMOVAL; ECONOMICS; EQUIPMENT; INCIDENCE; INDWELLING CATHETER; META ANALYSIS; PHLEBITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD; TIME;

CATHETER-RELATED INFECTIONS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; DEVICE REMOVAL; GUIDELINE ADHERENCE; HUMANS; INCIDENCE; PHLEBITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 84940284549     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007798.pub3     Document Type: Review

References (40)

1. Barker P, Anderson ADG, Macfie J. Randomised clinical trial of elective re-siting of intravenous cannulae. Annals of the Royal College of Surgeons of England 2004;86(4):281-3.
2. Nishanth S, Sivaram G, Kalayarasan R, Kate V, Ananthakrishnan N. Does elective re-siting of intravenous cannulae decrease peripheral thrombophlebitis? A randomized controlled study. The International Medical Journal of India 2009;22(2):60-2.
3. Rickard CM, McCann D, Munnings J, McGrail M. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Medicine 2010;8:53.
4. Rickard CM, Webster J, Wallis MC, Marsh N, McGrail MR, French V, et al.Routine versus clinically indicated replacement of peripheral intravenous catheters: A randomised equivalence trial. Lancet 2012;380(9847):1066-74.
5. Van Donk P, Rickard CM, McGrail MR, Doolan G. Routine replacement versus clinical monitoring of peripheral intravenous catheters in a regional hospital in the home program: A randomized controlled trial. Infection Control and Hospital Epidemiology 2009;30(9):915-7.
6. Webster J, Lloyd S, Hopkins T, Osborne S, Yaxley M. Developing a research base for intravenous peripheral cannula re-sites (DRIP trial). A randomised controlled trial of hospital in-patients. International Journal of Nursing Studies 2007;44(5):664-71.
7. Webster J, Clarke S, Paterson D, Hutton A, van Dyke S, Gale C, et al.Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial. BMJ 2008;337:a339.
8. Arnold RE, Elliot EK, Holmes BH. The importance of frequent examination of infusion sites in preventing postinfusion phlebitis. Surgery, Gynecology and Obstetrics 1977;145(1):19-20.
9. Cobb DK, High KP, Sawyer RG, Sable CA, Adams RB, Lindley DA, et al.A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. The New England Journal of Medicine 1992;327(15):1062-8.
10. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Critical Care Medicine 1990;18(10):1073-9.
11. Haddad FG, Waked CH, Zein EF. Peripheral venous catheter inflammation. A randomized prospective trial. Le Journal Médical Libanais 2006;54:139-45.
12. Kerin MJ, Pickford IR, Jaeger H, Couse NF, Mitchell CJ, Macfie J. A prospective and randomised study comparing the incidence of infusion phlebitis during continuous and cyclic peripheral parenteral nutrition. Clinical Nutrition 1991;10(6):315-9.
13. May J, Murchan P, MacFie J, Sedman P, Donat P, Palmer D, et al.Prospective study of the aetiology of infusion phlebitis and line failure during peripheral parenteral nutrition. British Journal of Surgery 1996;83(8):1091-4.
14. Nakae H, Igarashi T, Tajimi K. Catheter-related infections via temporary vascular access catheters: a randomized prospective study. Artificial Organs 2010;34(3):E72-6.
15. Panadero A, Iohom G, Taj J, Mackay N, Shorten G. A dedicated intravenous cannula for postoperative use. Effect on incidence and severity of phlebitis. Anaesthesia 2002;57(9):921-5.
16. Rijnders BJ, Peetermans WE, Verwaest C, Wilmer A, Van Wijngaerden E. Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Medicine 2004;30(6):1073-80.
17. Band JD, Maki DG. Steel needles used for intravenous therapy. Morbidity in patients with hematologic malignancy. Archives of Internal Medicine 1980;140(1):31-4.
18. Bregenzer T, Conen D, Sakmann P, Widmer AF. Is routine replacement of peripheral intravenous catheters necessary?. Archives of Internal Medicine 1998;158:51-6.
19. Catney MR, Hillis S, Wakefield B, Simpson L, Domino L, Keller S, et al.Relationship between peripheral intravenous catheter dwell time and the development of phlebitis and infiltration. Journal of Infusion Nursing 2001;24(5):332-41.
20. Cornely OA, Bethe U, Pauls R, Waldschmidt D. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infection Control and Hospital Epidemiology 2002;23:249-53.
21. Everitt NJ, Krupowicz DW, Evans JA, McMahon MJ. Ultrasonographic investigation of the pathogenesis of infusion thrombophlebitis. British Journal of Surgery 1997;84:642-5.
22. Gupta A Mehta Y, Juneja R, Trehan N. The effect of cannula material on the incidence of peripheral venous thrombophlebitis. Anaesthesia 2007;62:1139-42.
23. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistencies in meta-analysis. BMJ 2003;327(7414):557-60.
24. Higgins JPT, Deeks JJ. Selecting studies and collecting data. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Wiley-Blackwell, 2008.
25. Higgins JPT, Altman DG, and Sterne JAC on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
26. Ho KHM, Cheung DSK. Guidelines on timing in replacing peripheral intravenous catheters. Journal of Clinical Nursing 2011;21(11-12):1499-506.
27. Homer LD, Holmes KR. Risks associated with 72- and 96-hour peripheral intravenous catheter dwell times. Journal of Intravenous Nursing 1998;21:301-5.
28. Lai KK. Safety of prolonging peripheral cannula and i.v. tubing use from 72 hours to 96 hours. American Journal of Infection Control 1998;26:66-70.
29. Maddox RR, Rush DR, Rapp RP, Foster TS, Mazella V, McKean HE. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis. American Journal of Hospital Pharmacy 1977;34:29-34.
30. Maki DG, Goldman DA, Rhame FS. Infection control in intravenous therapy. Annals of Internal Medicine 1973;79(6):867-87.
31. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Annals of Internal Medicine 1991;114:845-54.
32. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proceedings 2006;81(9):1159-71.
33. Maki DG. Improving the safety of peripheral intravenous catheters. BMJ 2008;337(7662):122-3.
34. Monreal M, Quilez F, Rey-Joly C, Vega J, Torres T, Valero P, et al.Infusion phlebitis in patients with acute pneumonia: a prospective study. Chest 1999;115:1576-80.
35. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al.2011 Guidelines for the prevention of intravascular catheter-related infections. http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html.
36. Schunemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziuo P, et al.Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Available from www.cochrane-handbook.org.
37. Tager IB, Ginsberg MB, Ellis SE, Walsh NE, Dupont I, Simchen E, et al.The Rhode Island Nosocomial Infection Consortium. An epidemiologic study of the risks associated with peripheral intravenous catheters. American Journal of Epidemiology 1983;118(6):839-51.
38. Uslusoy E, Mete S. Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study. Journal of the American Academy of Nurse Practitioners 2008;20:172-80.
39. White SA. Peripheral intravenous therapy-related phlebitis rates in an adult population. Journal of Intravenous Nursing 2001;24:19-24.
40. Webster J, Osborne S, Rickard C, Hall J. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD007798.pub2].